Please wait while the formulary information is being retrieved.
VYTONE (hydrocortisone acetate/iodoquinol/aloe vera)
1.9 %-1 % topical cream packet
- Dosage information is not available
hydrocortisone 1.9 %-iodoquinol 1 %-aloe vera topical cream packet
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- Hypothalamic-pituitary insufficiency
VYTONE (hydrocortisone acetate/iodoquinol/aloe vera)
- None
- Erythema
- Stinging of skin
More Frequent
Severe
Less Severe
- Folliculitis
- Purpura
- Skin and skin structure infection
- Skin atrophy
- Acute pain at drug application site
- Headache disorder
- Paresthesia
- Pruritus of skin
- Skin irritation
- Skin rash
- Telangiectasia
- Treatment site sequelae
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Adrenocortical insufficiency
- Bullous dermatitis
- Cataracts
- Central serous chorioretinopathy
- Glaucoma
- Hypothalamic-pituitary insufficiency
- Ocular hypertension
- Skin hypopigmentation
- Skin striae
- Skin ulcer
- Urticaria
Less Severe
- Acneiform eruption
- Alopecia
- Blistering skin
- Contact dermatitis
- Dry skin
- Dyschromia
- Glycosuria
- Hirsutism
- Hypercortisolism
- Hyperesthesia
- Hyperglycemia
- Miliaria
- Perioral dermatitis
- Skin irritation
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Hydrocortisone (Top,Ophth,Rect)
Prolonged or extensive use may lead to systemic absorption; may affect growth rate.
Safety and efficacy not established.
- 1 Day – 18 Years
- Prolonged or extensive use may lead to systemic absorption; may affect growth rate.
- 1 Day – 12 Years
- Prolonged or extensive use may lead to systemic absorption; may affect growth rate.
Iodoquinol (Topical)
Prolonged or extensive use may lead to systemic absorption; may affect growth rate.
Safety and efficacy not established.
- 1 Day – 18 Years
- Safety and efficacy not established.
- 1 Day – 12 Years
- Safety and efficacy not established.
Hydrocortisone (topical, Non-systemic)
- Severity Level:
2
- Additional Notes: Insufficient human data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
Hydrocortisone (top., Rectal)
Insufficient data available; limited use may pose little risk
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Insufficient data available; limited use may pose little risk |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool